Showing results (81-90 of 187) with videos related to

Sort By:
Pageof 19
Pharmacogenomics|August 13, 2015
Translating DPYD genotype into DPD phenotype: using the DPYD gene activity scoreLinda M Henricks, Carin A T C Lunenburg, Didier Meulendijks, et al.
Clinical and Translational Science|July 16, 2024
Inflammation altered correlation between CYP2C19 genotype and CYP2C19 activity in patients receiving voriconazoleSylvia D Klomp, Anette Veringa, Jan-Willem C Alffenaar, et al.
Genes|March 29, 2023
Feasibility of Community Pharmacist-Initiated and Point-of-Care CYP2C19 Genotype-Guided De-Escalation of Oral P2Y12 InhibitorsAmar D Levens, Melina C den Haan, J Wouter Jukema, et al.
Clinical Pharmacology and Therapeutics|October 11, 2017
Comparison of the Guidelines of the Clinical Pharmacogenetics Implementation Consortium and the Dutch Pharmacogenetics Working GroupP C D Bank, K E Caudle, J J Swen, et al.
European Journal of Clinical Pharmacology|October 11, 2011
Feasibility of pharmacy-initiated pharmacogenetic screening for CYP2D6 and CYP2C19J J Swen, T van der Straaten, J A M Wessels, et al.
Therapeutic Drug Monitoring|July 9, 2025
Effect of CYP3A4 Methylation on Tacrolimus PharmacokineticsKarel K M Koudijs, Oumaima Etsouli, Costanza L Vallerga, et al.
Pharmacogenomics|November 7, 2013
Effect of genetic variants GSTA1 and CYP39A1 and age on busulfan clearance in pediatric patients undergoing hematopoietic stem cell transplantationMarloes H ten Brink, Tom van Bavel, Jesse J Swen, et al.
The Pharmacogenomics Journal|August 13, 2022
Development of an extensive workflow for comprehensive clinical pharmacogenomic profiling: lessons from a pilot study on 100 whole exome sequencing dataAlireza Tafazoli, Maaike van der Lee, Jesse J Swen, et al.
Pharmacogenomics|April 1, 2015
FcGR genetic polymorphisms and the response to adalimumab in patients with rheumatoid arthritisCristina Lucía Dávila-Fajardo, Tahar van der Straaten, Rene Baak-Pablo, et al.
Pharmacotherapy|April 30, 2024
Genetic polymorphisms and major bleeding risk during vitamin K antagonists treatment: The BLEEDS case-cohortEleonora Camilleri, Mira Ghobreyal, Mettine H A Bos, et al.
Pageof 19